Findmyvaccine

About Findmyvaccine

A national conversation with an unparalleled look into the leading minds that are shaping today's public health decisions, economic policies, regulatory and governance, and the emergence of a new normal.

Publisher

findmyvaccine, Pharmacy Leaders of Tomorrow

Category

education · health & fitness · society & culture

Language

en

Explicit

No

First episode

10 Aug 2021

Latest episode

19 Aug 2026

Latest episodes

32 episodes in the feed.

1. 

   19 Aug 2026

   Antibodies, Vaccines & Baby Season: An RSV Prevention Masterclass with Dr. Zain Chagla PART 2

   Episode Description RSV prevention now comes with options. Great news—until you have to decide who gets what, when, and how to make sure it actually happens. 🦠💉 In Part 2 of our conversation, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to take RSV prevention from the guideline page to the front lines. First up: timing really is everything. A baby born during RSV season may be best protected before leaving hospital. A baby born in July? Not so fast. Dr. Chagla explains why the goal isn’t simply to immunize at the earliest opportunity—it’s to line up the protection window with the infant’s period of greatest RSV exposure. Think less “ASAP” and more “right place, right season.” Then comes the big practical question: maternal vaccination or infant monoclonal antibody? We unpack gestational timing, the important two-week window before delivery, infant risk factors, family preference, local program availability—and why this conversation belongs in the birth plan, not as a surprise item at discharge. With multiple monoclonal antibody options now in the toolkit, we also ask: how do you actually choose one? Dr. Chagla walks through dosing, age and season indications, access, inventory and workflow considerations. And because guidelines always sound easier until an actual patient walks in, we put Zain through a special rapid-fire RSV rounds. ⚡ Four babies. Four different scenarios. No multiple-choice answers. A healthy baby born in July. A newborn delivered nine days after maternal RSV vaccination. A premature infant. A 14-month-old with chronic lung disease heading into season two. Dr. Chagla offers a practical way to explain risk without frightening parents or overselling protection. Finally, we finish with a Monday-morning checklist for clinicians. Because ultimately, the best RSV strategy isn’t necessarily the fanciest one. Learning Objectives By the end of this episode, listeners will be able to: Apply RSV seasonality to prevention timing, distinguishing the approach for infants born during versus outside peak RSV activity. Compare maternal RSV vaccination and infant monoclonal antibody strategies, considering gestational timing, infant risk, family preference and local program availability. Recognize situations where monoclonal antibody protection may still be appropriate, including insufficient time between maternal vaccination and delivery or increased infant risk. Evaluate practical factors involved in monoclonal antibody selection, including authorized indications, dosing, age, workflow, accessibility and second-season considerations. Apply RSV prevention recommendations to common real-world cases, including healthy infants, premature newborns and medically high-risk children. Counsel parents about RSV risk in a balanced and understandable way, setting realistic expectations about what preventive interventions can—and cannot—do. Identify practical system changes that can improve RSV prevention, #FindMyVaccine ️ #RSV #RSVPrevention #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #Pediatrics #InfectiousDiseases #NACI #PublicHealth #ClinicalPractice #VaccineEducation #NewbornHealth #CanadianHealthcare SUPPORTED BY AN IME GRANT FROM MERCK. About Dr. Zain Chagla HAMILTON, ON Dr.Zain  Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia. Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine. As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

2. 

   17 Aug 2026

   Antibodies, Vaccines & Baby Season: An RSV Prevention Masterclass with Dr. Zain Chagla

   Episode Description RSV prevention has entered its “more options, more questions” era. 👶🦠 In Part 1, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to help sort through what Canadian clinicians actually need to know about protecting infants from RSV. First up: who is really at risk? Spoiler—the answer is not just premature or medically fragile babies. Dr. Chagla explains why otherwise healthy, full-term infants can still end up hospitalized with RSV, why those first few months of life matter so much, and how to communicate that risk to families without turning counselling into a horror movie. We then tackle the updated NACI guidance and the increasingly important choice between maternal vaccination and long-acting monoclonal antibodies. Who should receive what? When does maternal vaccination leave an infant needing additional protection? And which higher-risk babies deserve a particularly proactive plan? Then comes the immunology—minus the painful lecture. Dr. Chagla explains why monoclonal antibodies are not vaccines, how passive immunization essentially gives infants ready-made RSV-fighting antibodies, and why newer long-acting options have changed the game from repeated injections to protection that can potentially cover much of an RSV season. And because percentages alone rarely tell the whole story, we dig into the evidence: pivotal trials, hospitalization outcomes, absolute risk reduction, high-risk infant data, and why comparing one RSV monoclonal antibody trial directly with another can get scientifically… messy. Bottom line: RSV prevention is no longer simply about knowing that options exist. It is about knowing which option, for which infant, at which time. Class is officially in session. 🎙️ Learning Objectives By the end of this episode, listeners will be able to: Describe the clinical burden of RSV in infants and explain why severe disease can occur even in previously healthy, full-term babies. Interpret updated Canadian RSV prevention guidance, including the respective roles of maternal vaccination and infant monoclonal antibodies. Identify infants who may warrant a more proactive monoclonal antibody strategy, including those with prematurity, cardiopulmonary disease, immunodeficiency, other medical risk factors, or barriers to timely healthcare access. Explain the difference between vaccination and passive immunization, including how long-acting monoclonal antibodies provide immediate protection against RSV. Translate RSV clinical trial results into practical clinical meaning, including relative efficacy, absolute reductions in hospitalization, and important limitations when comparing evidence across trials. Apply seasonality and local RSV surveillance when considering the timing of infant prevention strategies. #FindMyVaccine #RSV #RSVPrevention #InfantHealth #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #NACI #Pediatrics #InfectiousDiseases #VaccineEducation #PublicHealth #CanadianHealthcare Supported by an IME Grant from Merck

3. 

   13 Feb 2026

   BC Premier David Eby and the Provincial Healthcare Rethink

   ☎ What happens when you put BC’s biggest healthcare pain points on the table—and agree that “we’ve always done it this way” isn’t a strategy? 🗨️ In this special episode, BC Premier David Eby, joins us for a sit down candid, practical conversation about the realities of modernizing healthcare in British Columbia—starting with the unglamorous but high-impact stuff: cutting administrative duplication across health authorities, centralizing procurement and shared services, and creating clearer accountability so problems get fixed faster. 🎙️We explore what frontline clinicians want: a tighter feedback loop where ideas from pharmacists, nurses, physicians, and allied health don’t disappear into a “suggestion box” black hole and unpack the real promise—and real limits—of AI integration into day to day healthcare across BC: where it’s already helping, and what it takes to scale innovation safely with privacy protections. 🎙️BC Cancer—and the growing operational pressure of rising diagnoses, delayed access, and complex patient journeys. Premier Eby shares what’s underway and tackles a question that may be on the minds of HCPs and caregivers: do we need to revisit BC’s 10-year cancer plan to match today’s system realities and explore practical system fixes like patient navigators om the BC Cancer care pathway. 🎙️You’ll also hear a frank discussion on expanding pharmacy-delivered care, the pressures and possibilities of minor ailments and contraceptive services, and how new reimbursement models may unlock pharmacist impact beyond the walls of a community pharmacy. 🎙️This episode arguably tackles some of the toughest files facing the Ministry of Health: rare-disease drug reimbursement decisions, transparency and modernization in PharmaCare, balancing urgent access with fair pricing, and what meaningful accountability looks like when care delivery goes wrong.We also unpack regulation and oversight through the Health Professions Act: is it enough to protect the public and drive system-level learning, or do we need additional tools in the middle ground between individual college complaints and full-blown litigation? ▶️If you’re a frontline clinician, health leader, or policy-watcher who wants less theatre and more solutions—this one’s for you. 💡💡 In this episode, we look at: The role of a new provincial “shared services” model and health authority optimization What a province-wide AI strategy needs before it touches routine prescribing workflows Where pharmacist scope is heading—and what may be missing to make it sustainable Why rare-disease drug coverage decisions feel like a black box (and how to fix that) and Pharmacare The case for better patient navigation during their cancer care journey In collaboration with the Pharmacy Leaders of Tomorrow. Our hearts are with everyone affected—along with their families, friends, and the Tumbler Ridge, B.C. community—coping with an unimaginable loss during this heartbreaking time. ABOUT BC Premier Hon. David Eby, KC David Eby is a determined problem-solver who has spent a lifetime taking on powerful interests to get things done for people. As Premier of B.C., David is taking action on the biggest challenges facing British Columbians. He’s standing up to wealthy speculators and investors to deliver more homes middle-class people can afford. He’s working to ease the pressure of everyday costs, from reducing car insurance and childcare bills to making prescription birth control free. And he’s strengthening health care by building hospitals and hiring more family doctors. Under David’s leadership, B.C. is an economic leader in Canada—creating tens of thousands of good-paying jobs to deliver the lowest unemployment rate and some of the fastest growing wages in the country. Alongside John Horgan, David got the influence of big money out of B.C.’s elections and cracked down on money laundering in casinos and real estate. He took on opioid manufacturers and delivered a first-of-its-kind settlement to hold corporations accountable for the overdose crisis. He stood up to the trial lawyers and removed legal costs from ICBC process to reduce car insurance rates by an average of $500 a year for drivers.  He even went after organized crime—closing down Hells Angels clubhouses and targeting the proceeds of crime to make our communities safer. Before being elected as the MLA for Vancouver-Point Grey, David was an award-winning lawyer and legal scholar. He started his career on Vancouver’s Downtown Eastside, defending the homes of low-income people from big developers and slum lords. His work on human rights and democratic freedoms has been recognized by the United Nations Association in Canada and the B.C. Human Rights Coalition. David was an adjunct professor of law at the University of British Columbia, president of the HIV-AIDS Legal Network, and served on the Vancouver Foundation’s Health and Social Development Committee. From 2009 to 2013, David ran the B.C. Civil Liberties Association as executive director. David was raised in a suburban middle-class home. The son of a schoolteacher and a lawyer, he remains grounded in the values he grew up with – commitment to family, community, and helping the less fortunate. He is now a proud husband and father with three children of his own, Ezra, Iva, and baby Gwen. He loves playing with his kids, practising yoga and hanging out with his wife Cailey, a family doctor in Vancouver. As B.C.’s 37th premier, David is working hard to build a better, stronger future for everyone. Because he believes his kids and all British Columbians deserve the same opportunities to build a good life. #BCPolitics #BCHealth #Healthcare #CanadianHealthcare #HealthPolicy #HealthSystemReform #PrimaryCare #PatientSafety #QualityOfCare #PatientExperience #Accountability #PatientQualityCareReviewBoard #HealthProfessionsAct #Regulation #FrontlineHealthcare #Doctors #Nurses #Pharmacists #PharmacyPractice #ScopeOfPractice #MinorAilments #ContraceptionCare #WaitTimes #HealthEquity #DigitalHealth #AIinHealthcare #Innovation #CancerCare #BCCancer #Oncology #CancerPlan #PatientNavigation

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

1 ratings

Contact Findmyvaccine

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.